Israele - inglese - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - powder for inhalation - fluticasone propionate 250 mcg - fluticasone - fluticasone - prophylactic management of all grades of asthma.fluticasone propionate is indicated for the management of copd when used in combination with long-acting bronchodilators (e.g. long-acting beta agonists (labas)).

Israele - inglese - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - powder for inhalation - fluticasone propionate 50 mcg - fluticasone - fluticasone - prophylactic management of all grades of asthma.

Israele - inglese - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - inhalation suspension for nebulisation - fluticasone propionate 0.5 mg / 2 ml - fluticasone - fluticasone - in adults and adolescents over 16 years flixotide nebules can be used:for prophylactic management of severe chronic asthma in patients requiring high dose inhaled or oral corticosteroid therapy. it reduces symptoms and exacerbations of asthma in patients previously treated with other prophylactic therapy.children and adolescents from 4 to 16 years of age:treatment of acute exacerbations of asthma.

Israele - inglese - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - inhalation suspension for nebulisation - fluticasone propionate 2 mg / 2 ml - fluticasone - fluticasone - in adults and adolescents over 16 years flixotide nebules can be used:for prophylactic management of severe chronic asthma in patients requiring high dose inhaled or oral corticosteroid therapy. it reduces symptoms and exacerbations of asthma in patients previously treated with other prophylactic therapy.

Israele - inglese - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - suspension for inhalation - fluticasone propionate 250 mcg/dose - fluticasone - fluticasone - prophylactic management of all grades of asthma.fluticasone propionate is indicated for the management of copd when used in combination with long-acting bronchodilators (e.g. long-acting beta agonists (labas)).

Israele - inglese - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - suspension for inhalation - fluticasone propionate 125 mcg/dose - fluticasone - fluticasone - prophylactic management of all grades of asthma.

Israele - inglese - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - suspension for inhalation - fluticasone propionate 50 mcg/dose - fluticasone - glucocorticoids - prophylactic management of all grades of asthma.children aged 1 to 4 years:inhaled fluticasone propionate is of benefit to young children in the control of persistent asthma

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

bayer new zealand limited - fluconazole 150mg - capsule - 150 mg - active: fluconazole 150mg excipient: colloidal silicon dioxide gelatin lactose monohydrate magnesium stearate maize starch opacode black s-1-17823 sodium laurilsulfate titanium dioxide water - canesoral fluconazole capsule, given orally, is indicated for vaginal candidiasis.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

bayer new zealand limited - fluconazole 150mg; clotrimazole 10 mg/g - combination - 150mg & 10mg/g - active: fluconazole 150mg excipient: colloidal silicon dioxide gelatin lactose monohydrate magnesium stearate maize starch opacode black s-1-17823 sodium laurilsulfate titanium dioxide water active: clotrimazole 10 mg/g excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - vaginal candidiasis. cream can be used for relief of external itching/irritation and the management of candida vulvovaginitis or infection of the peri-anal area.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - micafungin 100mg - powder for injection - 100 mg - active: micafungin 100mg excipient: citric acid lactose nitrogen sodium hydroxide - treatment of invasive candidiasis in children & adults treatment of oesophageal candidiasis in adults, adolescents nlt 16 yrs of age, and elderly patients for whom intravenous therapy is appropriate prophylaxis of candida infection in children and adult patients undergoing allogenic haematopoietic stem cell transplantation or patients who are expected to have neutropenia (absolute neutrophil count below 500 cells per microliter) for 10 or more days